Showing results (181-190 of 595) with videos related to
Sort By:
Pageof 60
Expert Review of Clinical Immunology|April 2, 2019
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosusMaddalena Larosa, Teresa Del Ross, Antonia Calligaro, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2025
Mucosal-associated invariant T cells in rheumatic diseasesManon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.Medicine|September 30, 2016
Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patientsLorenzo Cavagna, Veronica Codullo, Stefano Ghio, et al.RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.Experimental Biology and Medicine (Maywood, N.J.)|January 22, 2019
IL-12 and IL-23/Th17 axis in systemic lupus erythematosusMaddalena Larosa, Margherita Zen, Mariele Gatto, et al.Radiology|September 7, 2013
Hand and wrist involvement in systemic sclerosis: US featuresVéronique Freire, Ramin Bazeli, Muriel Elhai, et al.Rheumatology (Oxford, England)|March 24, 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospitalSophie Hecquet, Alice Combier, Alexia Steelandt, et al.Annals of the Rheumatic Diseases|September 23, 2020
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosisYannick Allanore, Peter Wung, Christina Soubrane, et al.Therapie|April 27, 2019
French translation and linguistic validation of the Raynaud's condition scoreCharles Khouri, Sophie Blaise, Alicia Guigui, et al.Pageof 60